Ankylosing Spondylitis 1 Responsiveness and Discriminative Capacity of the Assessments in Ankylosing Spondylitis Disease-Controlling Antirheumatic Therapy Core Set and Other Outcome Measures in a Trial of Etanercept in Ankylosing Spondylitis, Astrid J. B. Wanders, Jennifer D. Gorman, John C. Davis, Robert B. M. Landewe, Désirée M. F. M. van der Heijde, Jeanne K. Tofferi, Jeffrey L. Jackson, Patrick G. O’Malley, Ayse A. Küçükdeveci, Hülya Sahin, Sebnem Ataman, Bridget Griffiths, Alan Tennant, Dominick L. Frosch, Robert M. Kaplan, Theodore G. Ganiats, Erik J. Groessl, William J. Sieber, Michael H. Weisman, Michielle N. Fisher, Soham Al Snih, Glenn V. Ostir, James S. Goodwin, G. Kelley Fitzgerald, Sara R. Piva, James J. Irrgang, Terence W. Starz, Larry Vandecreek, Stephen Paget, Roberta Horton, Laura Robbins, Margaret Oettinger, Katie Tai, Arja Häkkinen, Tuulikki Sokka, Pekka Hannonen, Maura D. Iversen, Holley M. Eaton, Lawren H. Daltroy, Graciela S. Alarcón, Gerald McGwin, Martha L. Sanchez, Holly M. Bastian, Barri J. Fessler, Alan W. Friedman, Bruce A. Baethge, Jeffrey Roseman, G. Ruiz-Irastorza, M. A. Khamashta
Maura Iversen
